iRhythm Technologies Inc
NASDAQ:IRTC

Watchlist Manager
iRhythm Technologies Inc Logo
iRhythm Technologies Inc
NASDAQ:IRTC
Watchlist
Price: 89.5 USD 0.15%
Market Cap: 2.8B USD
Have any thoughts about
iRhythm Technologies Inc?
Write Note

iRhythm Technologies Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

iRhythm Technologies Inc
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
iRhythm Technologies Inc
NASDAQ:IRTC
Cash Equivalents
$519.5m
CAGR 3-Years
46%
CAGR 5-Years
72%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$1.7B
CAGR 3-Years
-9%
CAGR 5-Years
26%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7.6B
CAGR 3-Years
-7%
CAGR 5-Years
13%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$1.8B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
14%
No Stocks Found

iRhythm Technologies Inc
Glance View

Market Cap
2.8B USD
Industry
Health Care

In the bustling realm of healthcare technology, where innovation meets necessity, iRhythm Technologies Inc. stands as a pivotal player, translating sophisticated algorithms into tangible, life-saving insights. Founded with the mission to redefine how cardiac care is delivered, iRhythm has pioneered its niche through the Zio platform—a sophisticated, wearable patch that monitors heart rhythms with precision. The Zio's elegant design belies its robust function, offering patients the comfort of continuous monitoring while living their daily lives. It gleans crucial data that is then transmitted to iRhythm's cloud-based platform, where advanced data analytics work tirelessly to think like a seasoned cardiologist, initially parsing through millions of heartbeats to identity potential abnormalities. As healthcare systems worldwide grapple with increasing demands and complexities, iRhythm's business model resonates well with the need for efficiency and effectiveness. The company generates revenue primarily through its patient-centric monitoring services, catering to healthcare providers who seek reliable diagnostic solutions. By billing insurers and healthcare institutions for the analytic results derived from the Zio patch, iRhythm seamlessly integrates into the cardiac care continuum. The blend of cutting-edge technology and strategic partnerships with healthcare providers not only fuels iRhythm's growth but also underscores a broader shift towards personalized and preventive medicine in cardiac care, demonstrating how strategic foresight can align with technical innovation to meet pressing healthcare challenges.

IRTC Intrinsic Value
55.54 USD
Overvaluation 38%
Intrinsic Value
Price

See Also

What is iRhythm Technologies Inc's Cash Equivalents?
Cash Equivalents
519.5m USD

Based on the financial report for Sep 30, 2024, iRhythm Technologies Inc's Cash Equivalents amounts to 519.5m USD.

What is iRhythm Technologies Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
72%

Over the last year, the Cash Equivalents growth was 994%. The average annual Cash Equivalents growth rates for iRhythm Technologies Inc have been 46% over the past three years , 72% over the past five years .

Back to Top